Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Steven C. Quay, M.D.$188M
Market Cap • 24/04/20242009
(há 15 anos)
2012
(12 years ago)
NASDAQ
Listagem
Seattle
Sede • Washington9
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ATOSSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.